þ
|
Quarterly Report Pursuant to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
o
|
Transition
Report Pursuant to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
Commission
File Number: 1-9819
|
Virginia
|
52-1549373
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
incorporation
or organization)
|
Identification
No.)
|
4551
Cox Road, Suite 300, Glen Allen, Virginia
|
23060-6740
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(804)
217-5800
(Registrant’s
telephone number, including area code)
|
Large
accelerated filer
|
o
|
Accelerated
filer
|
þ
|
Non-accelerated
filer
|
o (Do
not check if a smaller reporting company)
|
Smaller reporting
company
|
o
|
Page
|
|||
PART
I.
|
FINANCIAL
INFORMATION
|
||
Item
1.
|
Financial
Statements
|
||
Condensed
Consolidated Balance Sheets at September 30, 2008 (unaudited) and December
31, 2007
|
1
|
||
Condensed
Consolidated Statements of Operations for the three and nine months ended
September 30, 2008 and 2007 (unaudited)
|
2
|
||
Condensed
Consolidated Statement of Shareholders’ Equity for the nine months ended
September 30, 2008 and 2007 (unaudited)
|
3
|
||
Condensed
Consolidated Statements of Cash Flows for the nine months ended September
30, 2008 and 2007 (unaudited)
|
4
|
||
Notes
to Unaudited Condensed Consolidated Financial Statements
|
5
|
||
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
19
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
46
|
|
Item
4.
|
Controls
and Procedures
|
48
|
|
PART
II.
|
OTHER
INFORMATION
|
||
Item
1.
|
Legal
Proceedings
|
48
|
|
Item
1A.
|
Risk
Factors
|
49
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
49
|
|
Item
3.
|
Defaults
Upon Senior Securities
|
49
|
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
49
|
|
Item
5.
|
Other
Information
|
50
|
|
Item
6.
|
Exhibits
|
50
|
|
SIGNATURES
|
|
September
30,
|
December
31,
|
|||||||
2008
|
2007
|
|||||||
(unaudited)
|
||||||||
ASSETS
|
||||||||
Agency
RMBS:
|
||||||||
Pledged to counterparties, at
fair value
|
$ | 283,976 | $ | – | ||||
Unpledged, at fair
value
|
16,916 | 7,456 | ||||||
300,892 | 7,456 | |||||||
Securitized
mortgage loans, net
|
252,507 | 278,463 | ||||||
Investment
in joint venture
|
10,448 | 19,267 | ||||||
Other
investments
|
17,340 | 28,549 | ||||||
581,187 | 333,735 | |||||||
Cash
and cash equivalents
|
16,411 | 35,352 | ||||||
Other
assets
|
5,495 | 5,671 | ||||||
$ | 603,093 | $ | 374,758 | |||||
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
||||||||
LIABILITIES
|
||||||||
Repurchase
agreements
|
$ | 265,819 | $ | 4,612 | ||||
Securitization
financing
|
185,184 | 204,385 | ||||||
Obligation
under payment agreement
|
10,079 | 16,796 | ||||||
Other
liabilities
|
2,377 | 7,029 | ||||||
463,459 | 232,822 | |||||||
Commitments
and Contingencies (Note 13)
|
||||||||
SHAREHOLDERS’
EQUITY
|
||||||||
Preferred
stock, par value $0.01 per share, 50,000,000 shares authorized, 9.5%
Cumulative Convertible Series D, 4,221,539 shares issued and outstanding
($43,218 aggregate liquidation preference)
|
41,749 | 41,749 | ||||||
Common
stock, par value $0.01 per share, 100,000,000 shares authorized,
12,169,762 and 12,136,262 shares issued and outstanding,
respectively
|
122 | 121 | ||||||
Additional
paid-in capital
|
366,793 | 366,716 | ||||||
Accumulated
other comprehensive (loss) income
|
(6,041 | ) | 1,093 | |||||
Accumulated
deficit
|
(262,989 | ) | (267,743 | ) | ||||
139,634 | 141,936 | |||||||
$ | 603,093 | $ | 374,758 | |||||
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30,
|
September
30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Interest
income:
|
||||||||||||||||
Investments
|
$ | 7,719 | $ | 6,836 | $ | 20,375 | $ | 21,548 | ||||||||
Cash and cash
equivalents
|
158 | 637 | 659 | 2,163 | ||||||||||||
7,877 | 7,473 | 21,034 | 23,711 | |||||||||||||
Interest
expense
|
5,090 | 5,016 | 13,325 | 15,830 | ||||||||||||
Net
interest income
|
2,787 | 2,457 | 7,709 | 7,881 | ||||||||||||
(Provision
for) recapture of loan losses
|
(449 | ) | 127 | (796 | ) | 1,352 | ||||||||||
Net
interest income after (provision for) recapture of loan
losses
|
2,338 | 2,584 | 6,913 | 9,233 | ||||||||||||
Equity
in (loss) income of joint venture
|
(3,462 | ) | 576 | (5,153 | ) | 1,878 | ||||||||||
Gain
on sale of investments, net
|
331 | 21 | 2,381 | 21 | ||||||||||||
Fair
value adjustments, net
|
1,461 | – | 5,519 | – | ||||||||||||
Other
income (expense)
|
3,862 | 305 | 6,954 | (713 | ) | |||||||||||
General
and administrative expenses
|
(1,485 | ) | (800 | ) | (3,954 | ) | (3,089 | ) | ||||||||
Net
income
|
3,045 | 2,686 | 12,660 | 7,330 | ||||||||||||
Preferred
stock dividends
|
(1,003 | ) | (1,003 | ) | (3,008 | ) | (3,008 | ) | ||||||||
Net
income to common shareholders
|
$ | 2,042 | $ | 1,683 | $ | 9,652 | $ | 4,322 | ||||||||
Net
income per common share:
|
||||||||||||||||
Basic
|
$ | 0.17 | $ | 0.14 | $ | 0.79 | $ | 0.36 | ||||||||
Diluted
|
$ | 0.17 | $ | 0.14 | $ | 0.77 | $ | 0.36 | ||||||||
Preferred
Stock
|
Common
Stock
|
Additional
Paid-in
Capital
|
Accumulated
Other
Comprehensive
(Loss)
Income
|
Accumulated
Deficit
|
Total
|
|||||||||||||||||||
Balance
at December 31, 2007
|
$ | 41,749 | $ | 121 | $ | 366,716 | $ | 1,093 | $ | (267,743 | ) | $ | 141,936 | |||||||||||
Cumulative
effect of adoption of SFAS 159
|
– | – | – | – | 943 | 943 | ||||||||||||||||||
Net
income
|
– | – | – | – | 12,660 | 12,660 | ||||||||||||||||||
Other
comprehensive income:
|
||||||||||||||||||||||||
Change
in market value of securities and other investments
|
– | – | – | (4,753 | ) | – | (4,753 | ) | ||||||||||||||||
Reclassification
adjustment for net gains included in net income
|
– | – | – | (2,381 | ) | – | (2,381 | ) | ||||||||||||||||
Total
comprehensive income
|
5,526 | |||||||||||||||||||||||
Dividends
on common stock
|
– | – | – | – | (5,841 | ) | (5,841 | ) | ||||||||||||||||
Dividends
on preferred stock
|
– | – | – | – | (3,008 | ) | (3,008 | ) | ||||||||||||||||
Stock
option issuance
|
– | – | 13 | – | – | 13 | ||||||||||||||||||
Grant
and vesting of restricted stock
|
– | 1 | 64 | – | – | 65 | ||||||||||||||||||
Balance
at September 30, 2008
|
$ | 41,749 | $ | 122 | $ | 366,793 | $ | (6,041 | ) | $ | (262,989 | ) | $ | 139,634 |
Preferred
Stock
|
Common
Stock
|
Additional
Paid-in
Capital
|
Accumulated
Other
Comprehensive
(Loss)
Income
|
Accumulated
Deficit
|
Total
|
|||||||||||||||||||
Balance
at December 31, 2006
|
$ | 41,749 | $ | 121 | $ | 366,637 | $ | 663 | $ | (272,632 | ) | $ | 136,538 | |||||||||||
Net
income
|
– | – | – | – | 7,330 | 7,330 | ||||||||||||||||||
Other
comprehensive income:
|
||||||||||||||||||||||||
Change
in market value of securities and other investments
|
– | – | – | 433 | – | 433 | ||||||||||||||||||
Reclassification
adjustment for net gains included in net income
|
– | – | – | (21 | ) | – | (21 | ) | ||||||||||||||||
Total
comprehensive income
|
7,742 | |||||||||||||||||||||||
Dividends
on preferred stock
|
– | – | – | – | (3,008 | ) | (3,008 | ) | ||||||||||||||||
Stock
option exercise
|
– | – | 37 | – | – | 37 | ||||||||||||||||||
Stock
option issuance
|
– | – | 42 | – | – | 42 | ||||||||||||||||||
Balance
at September 30, 2007
|
$ | 41,749 | $ | 121 | $ | 366,716 | $ | 1,075 | $ | (268,310 | ) | $ | 141,351 |
|
DYNEX
CAPITAL, INC.
|
|
OF CASH FLOWS
(UNAUDITED)
|
|
(amounts
in thousands)
|
Nine
Months Ended
|
||||||||
September
30,
|
||||||||
2008
|
2007
|
|||||||
Operating
activities:
|
||||||||
Net
income
|
$ | 12,660 | $ | 7,330 | ||||
Adjustments
to reconcile net income to cash provided by operating
activities:
|
||||||||
Equity
in loss (income) of joint venture
|
5,153 | (1,878 | ) | |||||
Distribution
of joint venture earnings
|
– | 1,125 | ||||||
Provision
for (recapture of) loan losses
|
796 | (1,352 | ) | |||||
Gain
on sale of investments, net
|
(2,381 | ) | (21 | ) | ||||
Fair
value adjustments, net
|
(5,519 | ) | – | |||||
Amortization
and depreciation
|
(1,694 | ) | (1,518 | ) | ||||
Stock
based compensation (benefit) expense
|
(263 | ) | 42 | |||||
Net
change in other assets and other liabilities
|
(4,134 | ) | 2,883 | |||||
Net
cash provided by operating activities
|
4,618 | 6,611 | ||||||
Investing
activities:
|
||||||||
Principal
payments received on securitized mortgage loans
|
28,008 | 51,517 | ||||||
Purchases
of Agency RMBS
|
(343,941 | ) | – | |||||
Purchases
of other investments
|
(9,988 | ) | (16,398 | ) | ||||
Payments
received on Agency RMBS and other investments
|
21,171 | 8,230 | ||||||
Proceeds
from sales of Agency RMBS
|
29,744 | – | ||||||
Proceeds
from sales of other investments
|
19,188 | 452 | ||||||
Return
of capital from joint venture
|
– | 17,095 | ||||||
Other
|
(2,882 | ) | 931 | |||||
Net
cash (used) provided by investing activities
|
(258,700 | ) | 61,827 | |||||
Financing
activities:
|
||||||||
Principal
payments on securitization financing
|
(17,217 | ) | (27,119 | ) | ||||
Net
borrowings under (repayments of) repurchase
agreements
|
261,207 | (59,781 | ) | |||||
Proceeds
from sale of common stock
|
– | 37 | ||||||
Dividends
paid
|
(8,849 | ) | (3,008 | ) | ||||
Net
cash provided (used) by financing activities
|
235,141 | (89,871 | ) | |||||
Net
decrease in cash and cash equivalents
|
(18,941 | ) | (21,433 | ) | ||||
Cash
and cash equivalents at beginning of period
|
35,352 | 56,880 | ||||||
Cash
and cash equivalents at end of period
|
$ | 16,411 | $ | 35,447 | ||||
See
notes to unaudited condensed consolidated financial
statements.
|
Three
Months Ended September 30,
|
||||||||||||||||
2008
|
2007
|
|||||||||||||||
Income
|
Weighted-Average
Common Shares
|
Income
|
Weighted-
Average
Common
Shares
|
|||||||||||||
Net
income
|
$ | 3,045 | $ | 2,686 | ||||||||||||
Preferred
stock dividends
|
(1,003 | ) | (1,003 | ) | ||||||||||||
Net
income to common shareholders
|
2,042 | 12,169,762 | 1,683 | 12,136,262 | ||||||||||||
Effect
of dilutive items
|
– | 2,761 | – | 2,369 | ||||||||||||
Diluted
|
$ | 2,042 | 12,172,523 | $ | 1,683 | 12,138,631 | ||||||||||
Net
income per share:
|
||||||||||||||||
Basic
|
$ | 0.17 | $ | 0.14 | ||||||||||||
Diluted
|
$ | 0.17 | $ | 0.14 | ||||||||||||
Reconciliation
of shares included in calculation of income per share due to dilutive
effect:
|
||||||||||||||||
Net
effect of dilutive:
|
||||||||||||||||
Convertible
preferred stock
|
– | – | – | – | ||||||||||||
Stock
options
|
– | 2,761 | – | 2,369 | ||||||||||||
$ | – | 2,761 | $ | – | 2,369 |
Nine
Months Ended September 30,
|
||||||||||||||||
2008
|
2007
|
|||||||||||||||
Income
|
Weighted-Average
Common Shares
|
Income
|
Weighted-
Average
Common
Shares
|
|||||||||||||
Net
income
|
$ | 12,660 | $ | 7,330 | ||||||||||||
Preferred
stock dividends
|
(3,008 | ) | (3,008 | ) | ||||||||||||
Net
income to common shareholders
|
9,652 | 12,165,483 | 4,322 | 12,135,236 | ||||||||||||
Effect
of dilutive items
|
3,008 | 4,227,296 | – | 2,079 | ||||||||||||
Diluted
|
$ | 12,660 | 16,392,779 | $ | 4,322 | 12,137,315 | ||||||||||
Net
income per share:
|
||||||||||||||||
Basic
|
$ | 0.79 | $ | 0.36 | ||||||||||||
Diluted
|
$ | 0.77 | $ | 0.36 | ||||||||||||
Reconciliation
of shares included in calculation of income per share due to dilutive
effect:
|
||||||||||||||||
Net
effect of dilutive:
|
||||||||||||||||
Convertible
preferred stock
|
3,008 | 4,221,539 | – | – | ||||||||||||
Stock
options
|
– | 5,757 | – | 2,079 | ||||||||||||
$ | 3,008 | 4,227,296 | $ | – | 2,079 |
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30,
|
September
30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Shares
issuable under stock option awards
|
85,000 | 60,000 | 50,000 | 60,000 | ||||||||||||
Convertible
preferred stock
|
4,221,539 | 4,221,539 | – | 4,221,539 |
September
30,
2008
|
December
31, 2007
|
|||||||
Securitized
mortgage loans:
|
||||||||
Commercial
mortgage loans
|
$ | 171,028 | $ | 185,998 | ||||
Single-family
mortgage loans
|
73,230 | 86,088 | ||||||
244,258 | 272,086 | |||||||
Funds
held by trustees, including funds held for defeased commercial mortgage
loans
|
10,091 | 7,225 | ||||||
Accrued
interest receivable
|
1,664 | 1,940 | ||||||
Unamortized
discounts and premiums, net
|
6 | (67 | ) | |||||
Loans,
at amortized cost
|
256,019 | 281,184 | ||||||
Allowance
for loan losses
|
(3,512 | ) | (2,721 | ) | ||||
$ | 252,507 | $ | 278,463 |
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Allowance
at beginning of period
|
$ | 3,066 | $ | 2,805 | $ | 2,721 | $ | 4,495 | ||||||||
Provision
for (recapture of) loan losses
|
449 | (127 | ) | 796 | (1,352 | ) | ||||||||||
Charge-offs,
net of recoveries
|
(3 | ) | (30 | ) | (5 | ) | (495 | ) | ||||||||
Allowance
at end of period
|
$ | 3,512 | $ | 2,648 | $ | 3,512 | $ | 2,648 |
Investment
in Impaired Loans
|
Allowance
for Loan Losses
|
Investment
in Excess of Allowance
|
||||||||||
December
31, 2007
|
$ | 13,792 | $ | 2,590 | $ | 11,202 | ||||||
September
30, 2008
|
16,853 | 3,341 | 13,512 |
September
30,
2008
|
December
31, 2007
|
|||||||
Principal/par
value
|
$ | 299,012 | $ | 7,400 | ||||
Purchase
premiums
|
3,688 | 14 | ||||||
Purchase
discounts
|
(3 | ) | (4 | ) | ||||
Amortized cost
|
302,697 | 7,410 | ||||||
Gross
unrealized gains
|
68 | 46 | ||||||
Gross
unrealized losses
|
(1,873 | ) | – | |||||
Fair value
|
$ | 300,892 | $ | 7,456 | ||||
Weighted
average yield
|
5.15 | % | 5.43 | % |
Condensed
Statements of Operations
|
||||||||||||||||
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Interest
income
|
$ | 903 | $ | 1,551 | $ | 3,392 | $ | 4,468 | ||||||||
Fair
value adjustment
|
(1,584 | ) | (57 | ) | (5,846 | ) | 75 | |||||||||
Other-than-temporary
impairment
|
(6,073 | ) | – | (7,277 | ) | – | ||||||||||
Other
expense
|
(6 | ) | (25 | ) | (59 | ) | (62 | ) | ||||||||
Net
(loss) income
|
$ | (6,760 | ) | $ | 1,469 | $ | (9,790 | ) | $ | 4,481 | ||||||
Change
in unrealized loss on investments classified as available for
sale
|
1,276 | (591 | ) | (6,589 | ) | 624 | ||||||||||
Comprehensive
(loss) income
|
$ | (5,484 | ) | $ | 878 | $ | (16,379 | ) | $ | 5,105 |
Condensed
Balance Sheets
|
||||||||
September
30,
2008
|
December
31, 2007
|
|||||||
Assets:
|
||||||||
Cash
and cash equivalents
|
$ | 7,582 | $ | 5,592 | ||||
Investments
|
12,801 | 32,207 | ||||||
Accrued
interest receivable and other assets
|
264 | 173 | ||||||
$ | 20,647 | $ | 37,972 | |||||
Total
liabilities
|
$ | – | $ | – | ||||
Members’
capital:
|
||||||||
Members
capital
|
38,402 | 38,402 | ||||||
Accumulated
other comprehensive loss
|
(7,829 | ) | (1,239 | ) | ||||
Retained
(deficit) earnings
|
(9,926 | ) | 809 | |||||
$ | 20,647 | $ | 37,972 |
September
30, 2008
|
December
31, 2007
|
|||||||||||||||
Carrying
Value
|
Weighted
Average Yield
|
Carrying
Value
|
Weighted
Average Yield
|
|||||||||||||
Other
securities:
|
||||||||||||||||
Non-agency mortgage-backed
securities
|
$ | 7,051 | 7.17 | % | $ | 7,684 | 6.85 | % | ||||||||
Corporate debt
securities
|
– | – | % | 4,722 | 11.75 | % | ||||||||||
Equity securities of publicly
traded companies
|
7,653 | 7,704 | ||||||||||||||
14,704 | 20,110 | |||||||||||||||
Gross unrealized
gains
|
448 | 2,361 | ||||||||||||||
Gross unrealized
losses
|
(923 | ) | (696 | ) | ||||||||||||
14,229 | 21,775 | |||||||||||||||
Other
loans and investments
|
3,111 | 6,774 | ||||||||||||||
$ | 17,340 | $ | 28,549 |
Fair
Value Measurements
|
||||||||||||||||
Fair
Value
|
Level
1
|
Level
2
|
Level
3
|
|||||||||||||
Assets:
|
||||||||||||||||
Agency RMBS
|
$ | 300,892 | $ | – | $ | 300,892 | $ | – | ||||||||
Non-agency RMBS
|
6,822 | – | – | 6,822 | ||||||||||||
Equity securities
|
7,407 | 7,407 | – | – | ||||||||||||
Other
|
375 | – | – | 375 | ||||||||||||
Total assets carried at fair
value
|
$ | 315,496 | $ | 7,407 | $ | 300,892 | $ | 7,197 | ||||||||
Liabilities:
|
||||||||||||||||
Obligation under payment
agreement
|
$ | 10,079 | $ | – | $ | – | $ | 10,079 | ||||||||
Total liabilities carried at fair
value
|
$ | 10,079 | $ | – | $ | – | $ | 10,079 |
Level
3 Fair Values
|
||||||||||||||||||||
Non-agency
RMBS
|
Corporate
debt securities
|
Other
|
Total
assets
|
Obligation
under payment agreement
|
||||||||||||||||
Balance
at July 1, 2008
|
$ | 7,012 | $ | – | $ | 547 | $ | 7,559 | $ | 11,663 | ||||||||||
Total
realized and unrealized gains (losses)
|
||||||||||||||||||||
Included in
earnings
|
– | – | (2 | ) | (2 | ) | (1,584 | ) | ||||||||||||
Included in other comprehensive
income (loss)
|
(229 | ) | – | 143 | (86 | ) | – | |||||||||||||
Purchases,
sales, issuances and other settlements, net
|
39 | – | (313 | ) | (274 | ) | – | |||||||||||||
Transfers
in and/or out of Level 3
|
– | – | – | – | – | |||||||||||||||
Balance
at September 30, 2008
|
$ | 6,822 | $ | – | $ | 375 | $ | 7,197 | $ | 10,079 |
Level
3 Fair Values
|
||||||||||||||||||||
Non-agency
RMBS
|
Corporate
debt securities
|
Other
|
Total
assets
|
Obligation
under payment agreement
|
||||||||||||||||
Balance
at January 1, 2008
|
$ | 7,726 | $ | 4,347 | $ | 2,127 | $ | 14,200 | $ | 15,473 | ||||||||||
Total
realized and unrealized gains (losses)
|
||||||||||||||||||||
Included in
earnings
|
– | (187 | ) | (4 | ) | (191 | ) | (5,394 | ) | |||||||||||
Included in other comprehensive
income (loss)
|
(272 | ) | 375 | 143 | 246 | – | ||||||||||||||
Purchases,
sales, issuances and other settlements, net
|
(632 | ) | (4,535 | ) | (1,891 | ) | (7,058 | ) | – | |||||||||||
Transfers
in and/or out of Level 3
|
– | – | – | – | – | |||||||||||||||
Balance
at September 30, 2008
|
$ | 6,822 | $ | – | $ | 375 | $ | 7,197 | $ | 10,079 |
September
30, 2008
|
December
31, 2007
|
|||||||||||||||
Bonds
Outstanding
|
Range
of Interest Rates
|
Bonds
Outstanding
|
Range
of Interest Rates
|
|||||||||||||
Fixed-rate
classes
|
$ | 155,305 | 6.6% - 8.8 | % | $ | 167,398 | 6.6% - 8.8 | % | ||||||||
Variable-rate
classes
|
29,376 | 2.8 | % | 34,500 | 5.1 | % | ||||||||||
Accrued
interest payable
|
1,056 | 1,186 | ||||||||||||||
Unamortized
net bond premium and deferred costs
|
(553 | ) | 1,301 | |||||||||||||
$ | 185,184 | $ | 204,385 | |||||||||||||
Range
of stated maturities
|
2024-2027 | 2024-2027 | ||||||||||||||
Estimated
weighted average life
|
3.0
years
|
3.3
years
|
||||||||||||||
Number
of series
|
3 | 3 |
Shares
|
||||||||
Preferred
|
||||||||
Series
D
|
Common
|
|||||||
December
31, 2007
|
4,221,539 | 12,136,262 | ||||||
Restricted
shares granted
|
- | 33,500 | ||||||
September
30, 2008
|
4,221,539 | 12,169,762 |
Declaration
|
Record
|
Payment
|
Dividend
per Share
|
|||||||
Date
|
Date
|
Date
|
Common
|
Preferred
|
||||||
Common
Stock
|
||||||||||
February 5, 2008
|
February
15, 2008
|
February
29, 2008
|
$ | 0.10 | – | |||||
May 12, 2008
|
May
22, 2008
|
May
30, 2008
|
0.15 | – | ||||||
August 18, 2008
|
August
29, 2008
|
September
30, 2008
|
0.23 | – | ||||||
Preferred
Stock
|
||||||||||
March 19, 2008
|
March
31, 2008
|
April
30, 2008
|
– | $ | 0.2375 | |||||
June 18, 2008
|
June
30, 2008
|
July
31, 2008
|
– | 0.2375 | ||||||
September 18, 2008
|
September
30, 2008
|
October
31, 2008
|
– | 0.2375 |
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30, 2008
|
September
30, 2008
|
|||||||||||||||
Number
of Shares
|
Weighted-Average
Exercise Price
|
Number
of Shares
|
Weighted-
Average
Exercise
Price
|
|||||||||||||
SARs
outstanding at beginning of period
|
278,146 | $ | 7.27 | 278,146 | $ | 7.27 | ||||||||||
SARs
granted
|
– | – | – | – | ||||||||||||
SARs
forfeited or redeemed
|
– | – | – | – | ||||||||||||
SARs
exercised
|
– | – | – | – | ||||||||||||
SARs
outstanding at end of period
|
278,146 | $ | 7.27 | 278,146 | $ | 7.27 | ||||||||||
SARs
vested and exercisable
|
149,860 | $ | 7.41 | 149,860 | $ | 7.41 |
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30, 2008
|
September
30, 2008
|
|||||||||||||||
Number
of Shares
|
Weighted-Average
Exercise Price
|
Number
of Shares
|
Weighted-
Average
Exercise
Price
|
|||||||||||||
Options
outstanding at beginning of period
|
120,000 | $ | 8.60 | 95,000 | $ | 8.28 | ||||||||||
Options
granted
|
– | – | 25,000 | 9.81 | ||||||||||||
Options
forfeited or redeemed
|
– | – | – | – | ||||||||||||
Options
exercised
|
– | – | – | – | ||||||||||||
Options
outstanding at end of period
|
120,000 | $ | 8.60 | 120,000 | $ | 8.60 | ||||||||||
Options
vested and exercisable
|
120,000 | $ | 8.60 | 120,000 | $ | 8.60 |
SARs
Fair Value
|
|
September
30, 2008
|
|
Expected
volatility
|
18.06%-19.45%
|
Weighted-average
volatility
|
18.71%
|
Expected
dividends
|
11.93%
|
Expected
term (in months)
|
45
|
Risk-free
rate
|
3.97%
|
(amounts
in thousands)
|
September
30, 2008
|
December
31, 2007
|
||||||
Agency
RMBS, at fair value
|
$ | 300,892 | $ | 7,456 | ||||
Securitized
mortgage loans, net
|
252,507 | 278,463 | ||||||
Investment
in joint venture
|
10,448 | 19,267 | ||||||
Other
investments
|
17,340 | 28,549 | ||||||
Repurchase
agreements
|
265,819 | 4,612 | ||||||
Securitization
financing
|
185,184 | 204,385 | ||||||
Obligation
under payment agreement
|
10,079 | 16,796 |
(amounts
in thousands)
|
September
30, 2008
|
December
31, 2007
|
||||||
Hybrid
Agency RMBS:
|
||||||||
Fannie Mae
Certificates
|
$ | 209,534 | $ | – | ||||
Freddie Mac
Certificates
|
89,078 | – | ||||||
298,612 | – | |||||||
Fixed
Rate
|
266 | 7,456 | ||||||
298,878 | 7,456 | |||||||
Principal
receivable on Agency RMBS
|
2,014 | – | ||||||
$ | 300,892 | $ | 7,456 |
Lifetime
Caps on ARM RMBS
|
Interim
Interest Rate Caps on ARM RMBS
|
|||||
%
of Total
|
%
of Total
|
|||||
9.0% to
10.0%
|
19.79%
|
2.0%
|
44.90%
|
|||
>10.0% to
11.0%
|
54.27%
|
|
5.0%
|
55.10%
|
||
>11.0% to
12.0%
|
25.94%
|
100.00%
|
||||
100.00%
|
(amounts
in thousands)
|
September
30, 2008
|
December
31, 2007
|
||||||
Securitized
mortgage loans, net:
|
||||||||
Commercial
|
$ | 177,922 | $ | 190,570 | ||||
Single-family
|
74,585 | 87,893 | ||||||
252,507 | 278,463 |